Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 37; pp. 1 - 9
• Main Authors: Teruya, Takayuki, Chen, Yung-Ju, Kondoh, Hiroshi, Fukuji, Yasuhide, Yanagida, Mitsuhiro
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 14.09.2021
• Subjects: Adenosine triphosphate; Aged; Aging; Amino acids; Ammonium; Antioxidants; ATP; Biological Sciences; Biomarkers - blood; Brain; Brain - metabolism; Carnitine; Case-Control Studies; Central nervous system; Cognition; Cognitive ability; Dementia; Dementia - blood; Dementia - pathology; Dementia disorders; Erythrocytes; Glutathione; Humans; Liquid chromatography; Markers; Mass spectroscopy; Metabolites; Metabolome; Metabolomics; Methionine; NADP; Neuropsychological Tests; Neurotoxins; Quinolinic acid; Signal Transduction; Toxins; ergothioneine; dementia; Alzheimer’s disease; antioxidants; trimethyl-ammonium compounds
• ISSN: 0027-8424; 1091-6490; 1091-6490
• DOI: 10.1073/pnas.2022857118

Dementia is caused by factors that damage neurons. We quantified small molecular markers in whole blood of dementia patients, using nontargeted liquid chromatography–mass spectroscopy (LC-MS). Thirty-three metabolites, classified into five groups (A to E), differed significantly in dementia patients, compared with healthy elderly subjects. Seven A metabolites present in plasma, including quinolinic acid, kynurenine, and indoxyl-sulfate, increased. Possibly they act as neurotoxins in the central nervous system (CNS). The remaining 26 compounds (B to E) decreased, possibly causing a loss of support or protection of the brain in dementia. Six B metabolites, normally enriched in red blood cells (RBCs), all contain trimethylated ammonium moieties. These metabolites include ergothioneine and structurally related compounds that have scarcely been investigated as dementia markers, validating the examination of RBC metabolites. Ergothioneine, a potent antioxidant, is significantly decreased in various cognition-related disorders, such as mild cognitive impairment and frailty. C compounds also include some oxidoreductants and are normally abundant in RBCs (NADP⁺, glutathione, adenosine triphosphate, pantothenate, S-adenosyl-methionine, and gluconate). Their decreased levels in dementia patients may also contribute to depressed brain function. Twelve D metabolites contains plasma compounds, such as amino acids, glycerophosphocholine, dodecanoyl-carnitine, and 2-hydroxybutyrate, which normally protect the brain, but their diminution in dementia may reduce that protection. Seven D compounds have been identified previously as dementia markers. B to E compounds may be critical to maintain the CNS by acting directly or indirectly. How RBC metabolites act in the CNS and why they diminish significantly in dementia remain to be determined.